The forecasted Alzheimer's disease mortality rate among Canadian males is steady from 2024 to 2026, maintaining at 10.7 deaths per hundred thousand men, a slight decline from the 2023 base rate of 10.8. A slight further reduction to 10.6 is anticipated by 2028. Year-on-year variations indicate a stable pattern with negligible declines of about 0.93% in 2025 and maintain the rate in subsequent years. The compound annual growth rate (CAGR) over the next five years shows a minute average decline, signifying minimal fluctuation in mortality rates.

Future trends to watch for include:

Advancements in medical technology and treatments, potentially further reducing mortality rates.
Demographic shifts such as an aging population, which could influence mortality trends.
Policy changes and healthcare investment impacting long-term care for Alzheimer's patients.